Dermatix

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dermatix

Quick Facts

Property Description
Active ingredient Dimethicone (Polydimethylsiloxane)
Form Topical Gel or Silicone Sheet
Pharmacological class Miscellaneous Topical Agent (Silicone-Based)
Common use Scar Management and Prevention
Origin Synthetic Polymer Formulation

Defining Dermatix: Identity and Pharmacological Classification

Dermatix is classified as an over-the-counter (OTC) topical pharmaceutical preparation intended for scar management, falling under the broad category of silicone-based dermatological products. Its primary component, the silicone polymer Dimethicone (Polydimethylsiloxane), is pharmacologically identified as having Skin Barrier Activity. The product is designed exclusively for external use only and is manufactured by the Menarini Group. This preparation is a modern synthetic polymer formulation which functions as an occlusive emollient, a physical action recognized for aiding skin integrity and appearance.

Composition and Form: The Dimethicone Base and Differentiation

The core composition of Dermatix utilizes the long-chain silicone polymer Dimethicone, typically blended with volatile silicones such as Cyclopentasiloxane (CPX). This blend facilitates the quick-drying, non-greasy texture, which is a differentiating factor for the gel formulation, allowing for convenient use on visible areas. The product is most commonly prepared as a clear, quick-drying Topical Gel, although similar silicone technology is also available in Silicone Sheet form. Certain advanced versions of Dermatix are classified as combination products, as they integrate components like a Vitamin C Ester to further support skin uniformity.

General Purpose: The Role of Silicone in Scar Management

The general purpose of Dermatix is to assist the skin in optimizing its post-injury repair process after a wound has closed. Silicone sheeting and gel products are widely utilized for their application in managing closed, elevated scars, including hypertrophic scars and keloids. By maintaining stable tissue temperature and hydration beneath its protective film, the preparation assists the skin in normalizing the organization of collagen fibers. The high-level therapeutic goal is consequently to help the scar tissue become noticeably softer, flatter, and smoother.

What side effects are possible with Dermatix?

Possible side effects and safety information

The official safety documentation for this topical silicone preparation primarily identifies adverse effects classified as localized dermatological reactions. These reactions are generally categorized as occurring on rare occasions in regulatory texts, limiting their scope to the application site.


Documented Adverse Reactions and Frequency

Category Description
Adverse Reactions Temporary redness, stinging, burning, or irritation. A localized rash may sometimes be observed, often associated with inadequate cleansing of the scar area before application.
Frequency Classification Adverse effects are documented as occurring on rare occasions.

Official Safety Constraints

Regulatory labeling specifies high-level constraints and conditions for use. The product is for external use only, and contact with eyes, lips, or mucous membranes must be avoided. The preparation is contraindicated in individuals with a known hypersensitivity to Dimethicone or any other component.

Furthermore, the gel must not be applied on broken or infected skin, open wounds, or third-degree burns, as outlined in government regulatory warnings.

Population-Specific Notes

The regulatory profile includes specific statements regarding special populations. For pregnancy, available data are limited, but no induction of risk to the fetus has been officially reported. For lactation, it is officially stated that it is not known whether the preparation is excreted in human breast milk.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Dermatix, which contains the topical silicone polymer Dimethicone, reflects its highly inert nature and negligible systemic absorption. As a result, government regulatory labeling provides no documentation of specific systemic clinical signs, symptoms, or laboratory findings resulting from the topical application of excessive amounts of the product. No severe or life-threatening systemic outcomes are formally documented in official prescribing information following topical use.

The sole circumstance explicitly addressed by regulatory authorities that mandates urgent action is accidental ingestion of the product.

Condition Mandating Action Required Emergency Action (As Labeled)
Accidental Ingestion (Swallowing) Seek immediate medical help or contact a poison control center right away.

This emergency action is strictly required to determine the appropriate response following the ingestion of the product. The official prescribing information does not document the existence of a specific antidote for the active ingredient. Furthermore, specific medical procedures, requirements for hospital observation, or population-specific considerations (such as increased risk in children or the elderly) are not detailed in the official over-the-counter drug labeling. The entire scope of the official help-seeking condition is defined by the requirement to contact emergency services immediately upon accidental swallowing.

Therapeutic Uses of Dermatix

What Dermatix Treats: Main Uses and Benefits

Dermatix is a topical silicone-based preparation primarily used for the management and reduction of various types of scars. It is designed to improve the physiological and cosmetic appearance of skin that has undergone trauma or surgical intervention.

Primary Uses

Dermatix is indicated for the management of hypertrophic scars and keloids. These conditions often arise following:

  • Surgical Procedures: Scars resulting from incisions, including post-operative recovery.
  • Traumatic Injuries: Scars formed after deep cuts, abrasions, or lacerations.
  • Burns: Skin damage resulting from thermal or chemical burns once the wound has closed and healed.

Mechanism and Benefits

The application of silicone gel or sheeting works by creating a protective barrier over the scarred area. This process provides several specific benefits for scar maturation:

  • Flattening and Softening: Regular use helps to reduce the elevation of raised scars, making them softer and more level with the surrounding skin.
  • Reduction of Discoloration: It aids in fading the redness or hyperpigmentation associated with newly formed scars, helping them blend more naturally with the patient's skin tone.
  • Relief of Physical Discomfort: By maintaining a hydrated environment, it helps to alleviate common symptoms associated with scarring, such as itching and general discomfort.
  • Elasticity Improvement: The treatment supports the maintenance of moisture balance in the scar tissue, which can improve the overall flexibility and texture of the skin in the affected area.

Regulatory References

  1. NIH MedlinePlus guidance on keloids

Eligibility and Restrictions for Use

Who Can and Cannot Use Dermatix? Official Regulatory Information

The eligibility profile for Dermatix, a topical silicone gel, is primarily defined by local application site factors and is consistent across general age groups due to its non-systemic nature.

Populations Allowed and Contraindicated

Classification Population/Condition Eligibility Status
Allowed Adults, Older Adults Generally permitted
Contraindicated Patients with hypersensitivity to any gel ingredient. Must not use
Contraindicated Application to open, unhealed, or infected wounds. Must not use

Age and Physiological State Eligibility

Category Regulatory Statement
Pediatric Use Approved for use in infants and children, with some formulations specified for ages three to six months and older. Use is generally not contraindicated in this age group.
Systemic Conditions No official restrictions based on hepatic or renal impairment are documented, reflecting the product’s minimal to no systemic absorption.
Pregnancy Official information notes insufficient data to establish safety; use requires consultation.
Lactation Permitted for nursing mothers as it does not enter the bloodstream, with the condition that the gel must be wiped off the chest area before breastfeeding.

Official Eligibility Statements: The medicine is strictly contraindicated for use on mucous membranes and areas concurrently treated with other topical antibiotic preparations. The regulatory profile permits broad use but places an absolute prohibition on application to any wound that is not fully closed and healed.

What should I know about interactions with other medicines?

The official regulatory profile for Dermatix (topical Dimethicone) is determined by its active ingredient's pharmacological classification as a non-systemically absorbed topical agent. This means the substance does not reach the bloodstream at levels high enough to cause systemic effects or interact with other medicines taken internally.


Interaction Scope and Constraints

Category Official Regulatory Status
Systemic Drug-Drug Interactions None documented. The lack of systemic exposure precludes Dimethicone from altering the metabolism or plasma concentration of co-administered medicines.
Mechanistic Basis of Interactions Absence of systemic pharmacokinetic interactions. The official profile is based on the negligible to absent systemic absorption of Dimethicone.
Formal Contraindicated Combinations None documented. No substances are formally classified as contraindicated for co-administration due to systemic interaction risk.
Timing-Based Separation Rules None documented. No mandatory time separation rules are required between this topical application and the administration of systemic drugs.

Regulatory Status Summary

The regulatory documentation defines the interaction structure based on the active ingredient's inability to participate in common systemic metabolic or transporter pathways. This profile confirms the product does not require specific cautions for co-administration with other prescription drugs or over-the-counter medicines. Furthermore, there are no official warnings or restrictions listed concerning use with food, alcohol, or supplements.

Mechanism of Action

Modulation of Tissue Water Dynamics and Cellular Signaling

This mechanistic domain covers the biophysical action of the silicone polymer film, which acts as a semi-occlusive barrier on the Stratum Corneum. By regulating Trans-Epidermal Water Loss (TEWL), the increased hydration alters keratinocyte signaling, which initiates a molecular cascade. This action influences the activity of underlying dermal fibroblasts, leading to the physiological effect of modulating the volume and structure of the tissue matrix.


Downregulation of Fibrotic Growth Factor Pathways

The resulting modulation of the epidermis functionally suppresses the release of excessive profibrotic signaling molecules, such as Transforming Growth Factor beta-1 (TGF-beta1). This modulation dampens the intensity of the communication pathway between the epidermis and the dermis. This mechanism directly influences the fibroblast's proliferative signaling, modulating collagen homeostasis (synthesis versus breakdown), which affects the deposition pattern of the extracellular matrix.


Synergistic Interference with the Melanogenesis Pathway

The secondary component, a Vitamin C Ester, provides a complementary molecular mechanism distinct from the silicone's biophysical action. This molecule exerts a local antioxidant effect and interferes with the enzymatic process of melanin production (melanogenesis). This action modulates the pigmentation pathway, influencing the tissue's color profile.

Dosage and Administration Information

Instruction Map: How to Use Dermatix — Official Administration Guidelines

Administration Scope Detail
Route of administration Topical (external use only). Treatment is reserved for application on healed, intact skin and must not be used on open or weeping wounds.
Dosing schedule The regulated dosing requires applying a very thin layer to the scar area; the applied amount must be limited to ensure the gel dries completely within minutes.
Preparation requirements The application site must be cleaned and fully dried before application. If the gel does not dry quickly, it indicates over-application, and the excess should be gently removed.
Age-group administration rules The application of the silicone gel preparation is suitable for children.

Resulting Procedural Structure

Official use sequence:

  • Preparation: Clean and fully dry the scar area thoroughly before beginning application.
  • Application: Apply a very thin layer of the silicone gel to cover the entire affected area.
  • Timing: Allow the applied layer to air-dry completely for 3 to 5 minutes before covering with clothing or applying other topical products.
  • Maintenance: Maintain the twice-daily frequency throughout the entire course of use.

Connection to the overall use protocol (2–4 sentences): Official instructions establish a structured, non-systemic use protocol that defines the necessity of applying the product only to closed and intact skin on a twice-daily schedule. The strict requirements for a thin layer and dedicated drying time ensure the proper formation of the topical silicone film. This regimen must be followed for a documented minimum duration of 90 days to align with the recommended use period found in authoritative guidance.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dermatix

The available research for silicone-based products, such as Dermatix, centers on studies exploring patterns related to elevated scars and their development. The findings described in this overview are based on clinical studies, including comparative trials and systematic reviews published in scientific literature.


Evidence for Use in Hypertrophic Scars

Research exploring the use of silicone gel on hypertrophic scars—elevated, firm scars confined to the original injury boundary—has been conducted primarily through Randomized Controlled Trials (RCTs). Studies explored outcomes related to physical discomfort and scar characteristics. Researchers used objective scales to monitor parameters such as scar height, pliability (softness), and vascularity (redness). Research reports how symptoms evolved in the observed populations, and findings describe patterns observed in the studies related to measured changes in these scar characteristics.

Methodological differences across the body of research affect the certainty of the evidence. Furthermore, the long-term outcomes are not fully established beyond the typical observation periods of one year or less.


Evidence for Use in Keloid Scars

The research base for keloid scars—scars that grow beyond the boundaries of the original injury—includes RCTs and synthesis from Systematic Reviews. These studies focused on outcomes describing scar dimensions, such as measured size and volume, along with monitoring recurrence after intervention. Findings indicate that silicone products were observed in some studies to be associated with patterns in dimensional stability and pliability.

Evidence quality varies across studies, and there is a limited number of large-scale RCTs dedicated exclusively to this type of scar. Data for certain groups remain insufficient, and long-term recurrence rates are an area where certainty remains low.


What is Still Uncertain About the Research

The research provides insight into short-term changes and helps contextualize how patients reported their experience. However, there are recognized research limitation frames within the existing literature. Comparative evidence is lacking in some areas, and long-term outcomes are not fully established.

It is important to understand that research describes group patterns, not personal outcomes. Study results reflect the specific conditions under which they were conducted and research does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Dermatix (FAQ)

Q: Is Dermatix the same as silicone sheeting for scars?

A: Official product information indicates that Dermatix is a brand that offers products for scar management. It is available as a silicone gel, but the brand also manufactures a separate form called a Silicone Sheet. Therefore, while both are silicone-based scar treatments, they are available as different product formats.

Q: Does Dermatix work on old scars, or just new ones?

A: Official information states the product is intended for the management of both old and new hypertrophic and keloid scars. The best results are typically observed when application begins as soon as the wound is fully healed.

Q: Can Dermatix make a scar completely disappear?

A: The product is indicated to help flatten, soften, and fade scars. Official regulatory information describes its goal as improving scar appearance, not completely removing or erasing the scar.

Q: What is the difference between Dermatix Ultra and Dermatix regular gel?

A: Dermatix Ultra contains a more advanced silicone technology called Cyclopentasiloxane (CPX) alongside a Vitamin C Ester ingredient. The added Vitamin C Ester is specifically included to help address hyperpigmentation (darkening) of the scar tissue.

Q: Is it normal to feel a slight sticky residue after applying Dermatix?

A: A sticky residue is not expected. Official application instructions state that if the gel does not dry completely within the recommended 4–5 minutes, it is a sign of over-application. If this occurs, the excess product should be gently removed.

Q: Does Dermatix leave a residue on clothing?

A: Yes, regulatory precautions note that the gel may stain clothing if it has not been allowed to completely dry before dressing or covering the area. It is important to wait the full drying time before applying clothes.

Q: How long does a tube of Dermatix typically last?

A: The recommended dosage is a very small amount. A standard 15g tube contains enough product to last approximately two months of treatment when used as directed on a typical scar.

Q: Is Dermatix available over the counter, or is a prescription needed?

A: Dermatix Silicone Gel is generally available over the counter (OTC) and can be obtained without a prescription in many regions. However, product classification can vary by country.

Q: Do I need to massage Dermatix into the scar, or just spread it on?

A: Application instructions advise gently spreading a very thin layer over the entire affected area. It is explicitly recommended in the official instructions not to massage the area during application.

Q: What happens if I stop using Dermatix before the recommended duration?

A: The minimum recommended treatment time is two to three months (60 to 90 days). Discontinuing use before this duration may prevent the achievement of the intended cosmetic benefits of scar softening and fading.

Q: Why is silicone a key ingredient in scar gels like Dermatix?

A: Silicone is a key ingredient because it is a polymer that forms a protective, semi-occlusive barrier on the skin's surface. This barrier helps prevent excessive water loss from the tissue, which in turn normalizes collagen production and is necessary for minimizing scar formation.

Q: Is Dermatix waterproof after it dries?

A: The formulation is designed to form a silicone film that is resistant to washing off once it has dried completely. This allows the product to maintain its function even during activities like showering.

Q: Does applying a thicker layer of Dermatix make it work better?

A: Official instructions indicate that a very thin layer should be applied. Applying too much product does not increase effectiveness and prevents it from drying in the recommended time frame.

Q: Is a tingling sensation normal after applying Dermatix?

A: While the product is generally tolerated well, official safety information mentions that a temporary stinging sensation has been reported in specific circumstances. If persistent redness, pain, or severe irritation is experienced, official safety information recommends speaking with a healthcare professional.

Q: Why do some people use Dermatix for acne scars?

A: Manufacturer information explicitly lists acne scars as one of the common use cases for the gel. It is indicated for the management of scars that result from skin conditions such as acne.

Q: Is it okay to store Dermatix in the refrigerator?

A: Regulatory guidance advises storing the gel at room temperature, which is below 25 C, and to keep it away from excessive heat or extreme cold. Refrigeration is not recommended for this product.

Q: What should I do if the gel flakes or pills after application?

A: Official instructions indicate that flaking or pilling is typically a sign of over-application. The advice is to gently remove the excess product to ensure only a thin layer remains to dry correctly.

Q: Can Dermatix be used on burn scars?

A: Yes, official product information confirms that Dermatix Ultra can be applied to burn scars. However, it is strictly indicated for use only on wounds that are fully closed and healed.

Q: What are the inactive ingredients in Dermatix?

A: The inactive ingredients in some formulations include silicones such as Cyclopentasiloxane, Phenyl Trimethicone, Polysilicone-11, and Polymethylsilsesquioxane. These components help the product achieve its quick-drying, non-greasy texture.

Q: Why is it advised to use only a small amount of Dermatix?

A: Using only a very thin layer is essential because it is necessary for the gel to dry completely within minutes. This quick drying time allows the product to form the silicone sheet-like protective barrier required for its function.

Q: Are there different formulations of Dermatix for different skin types?

A: The official documentation does not specify different formulations based on general skin type. However, it is noted that Dermatix Ultra is safe to use on sensitive and allergy-prone skin.

Q: What is the consistency of the Dermatix gel?

A: Dermatix gel is described as a clear, quick-drying gel. Its silicone composition gives it a consistency that is generally non-greasy and leaves a soft, silky feel on the skin.

Q: Do the effects of Dermatix stop once treatment is finished?

A: The product works by regulating the production of collagen during the body's natural healing process. Its effect is to influence the permanent structural formation of the scar tissue itself, which remains after the treatment course is finished.

Q: Are there specific body areas where Dermatix works better?

A: Official product information states that the silicone gel is easily applied to most areas of the body, including challenging areas such as the face, joints, and other body contours.

Q: Can Dermatix be used on facial scars?

A: While the gel can be applied to the face, regulatory safety constraints state that direct contact with the eyes, lips, and mucous membranes must be avoided. It is indicated only for the non-mucosal skin of the face.

Q: Can I apply makeup or sunscreen over Dermatix gel?

A: Instructions advise allowing the gel to air-dry completely for 3 to 5 minutes before applying other topical products. This includes makeup, sunscreen, or any other cosmetic product you may wish to use over the scar.

Q: Is the Vitamin C in Dermatix Ultra supposed to help with pigmentation?

A: Yes, the Vitamin C Ester is included in the Dermatix Ultra formulation to provide a complementary action. This ingredient is intended to help modulate the pigmentation pathway and improve the tissue’s color profile, thereby reducing hyperpigmentation (darkening) of the scar.

Q: Can Dermatix be used under an occlusive dressing or bandage?

A: The product itself works by forming a breathable, semi-occlusive barrier over the scar. While the information doesn't explicitly prohibit bandages, it is designed to work effectively when applied directly to the skin and allowed to dry without further covering.

Q: Can I use Dermatix while also using other systemic medicines?

A: The active ingredient, Dimethicone, is a topical agent that is not absorbed into the bloodstream at significant levels. Therefore, regulatory documentation indicates there are no documented systemic drug-drug interactions with other medicines taken internally (systemic drugs).

Q: Does Dermatix help with the discoloration (redness/darkness) of a scar?

A: Yes, the product contains ingredients designed to influence the tissue's color profile and modulate the pigmentation pathway. This mechanism is intended to help with the appearance of discoloration, including both redness and darkness, of the scar tissue.

Q: Why is continuous use important for the efficacy of Dermatix?

A: Continuous use is important because the gel must be applied twice daily over a period of at least 60 to 90 days. Maintaining this consistent application ensures the silicone barrier is continuously in place to regulate hydration and optimize the scar maturation process.

Q: Does sun exposure affect how well Dermatix works?

A: Protecting the scar from the sun is widely advised during the healing process to help prevent hyperpigmentation (darkening).

How should Dermatix be stored and disposed of?

Storage Conditions and Requirements

The gel formulation must be stored at temperatures below 25°C and away from heat sources to preserve its stability.

Specific formulations, such as Dermatix Ultra Gel, must be kept in a dry place and protected from light and moisture.

To maintain the product’s integrity, the container must be kept tightly closed after every use.

Constraint Type Required Action
Temperature Store below 25 C (or 5 C to 25 C for Wound Care)
Protection Keep away from heat, light, and moisture
Child Safety Keep out of the sight and reach of children
Stability Do not use after the expiry date

Disposal Instructions

Expired or unused Dermatix must be handled responsibly. For all medicinal waste, the consumer should consult their local municipality or pharmacy for official guidance on collection or take-back programs.

If local programs are unavailable, U.S. FDA guidelines recommend mixing the product with an undesirable substance (such as coffee grounds) and placing it in a sealed container before discarding it in the household trash. Identifying information on the label should be obscured before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dermatix found in:

A-Z Index: